Advertisement
Screener

Organon & Co. (OGN) Net Margin

Organon & Co. (OGN) Net Margin

  • 2026-06-30: Net Margin 6.93%.
  • 2026-03-31: Net Margin 10.00%.
  • 2025-12-31: Net Margin -13.60%.
  • 2025-09-30: Net Margin 9.99%.

Complete source-backed net margin history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-306.93%
2026-03-3110.00%
2025-12-31-13.60%
2025-09-309.99%
2025-06-309.10%
2025-03-315.75%
2024-12-316.85%
2024-09-3022.69%
2024-06-3012.13%
2024-03-3112.39%
2023-12-3134.17%
2023-09-303.82%
2023-06-3015.05%
2023-03-3111.51%
2022-12-317.27%
2022-09-3014.77%
2022-06-3014.76%
2022-03-3122.21%
2021-12-3112.60%
2021-09-3020.19%
2021-06-3026.77%
2021-03-3126.49%
2020-12-3122.81%
2020-09-3033.91%
2020-06-3035.52%
2020-03-3139.49%

Annual Net Margin

DateNet Margin
2025-12-313.01%
2024-12-3113.49%
2023-12-3116.33%
2022-12-3114.85%
2021-12-3121.43%
2020-12-3133.07%
2019-12-3141.38%

Similar stocks

Stock NameCountryMarket CapPE Ratio
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53